2327.HK HKSE
Meilleure Health International Industry Group Limited
1W: -6.1%
1M: -9.8%
3M: -13.6%
YTD: -9.2%
1Y: -14.8%
3Y: -15.8%
5Y: -42.5%
HK$0.21 ($0.03)
-0.00 (-1.39%)
Weekly Expected Move ±3.9%
HK$0
HK$0
HK$0
HK$0
HK$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$37M
-27.9% ▼
5Y CAGR: -32.7%
Gross Profit
$23M
-21.7% ▼
5Y CAGR: -27.3%
Operating Income
-$11M
-183.0% ▼
Net Income
$38M
+16.9% ▲
5Y CAGR: -14.6%
EPS (Diluted)
$0.01
+19.0% ▲
5Y CAGR: -13.6%
EBITDA
-$11M
-119.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $253M | $120M | $129M | $51M | $37M |
| YoY Growth | -4.6% | -52.6% | +7.8% | -60.8% | -27.9% |
| Cost of Revenue | $152M | $53M | $51M | $22M | $14M |
| Gross Profit | $101M | $67M | $78M | $29M | $23M |
| Gross Margin | 39.9% | 55.7% | 60.4% | 57.0% | 62.0% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $43M | $36M | $39M | $32M | $34M |
| Operating Expenses | $48M | $33M | $55M | $32M | $34M |
| Operating Income | $53M | $32M | $39M | -$4M | -$11M |
| Operating Margin | 21.0% | 26.9% | 30.4% | -7.6% | -29.9% |
| Interest Expense | $8M | $11M | $11M | $10M | $9M |
| Income Before Tax | $86M | $25M | $53M | $45M | $31M |
| Tax Expense | $25M | $8M | $14M | $13M | -$7M |
| Net Income | $60M | $18M | $41M | $32M | $38M |
| Net Margin | 23.8% | 14.9% | 31.6% | 64.1% | 104.0% |
| EPS (Diluted) | $0.01 | $0.00 | $0.01 | $0.01 | $0.01 |
| EBITDA | $109M | $55M | $71M | $57M | -$11M |
| Shares Outstanding | 4.27B | 4.11B | 4.09B | 4.09B | 4.06B |